Biomaterials, Tissue Engineering, and Regenerative Medicine

Research in biomaterials and tissue engineering focuses on designing materials for use in medical devices, drug delivery, and regenerative therapies, as well as developing platforms that precisely control biochemical and mechanical cues to study how cells and tissues respond to their environment. At CU Anschutz, these approaches are applied across a wide range of problems, including cardiac development and regeneration, lung disease modeling, ocular therapeutics, and the repair of bone and muscle defects.


Faculty with Research in this Area

Alberto Cruz-Martín PhD

Associate Professor
Anesthesiology
We are a dynamic and collaborative research group dedicated to understanding how neural circuits are wired, maintained, and disrupted in disease.

Peter Fecci MD, PhD

Professor
Neurosurgery
The Fecci Lab works to define key mechanisms of immune failure in glioblastoma and brain metastases and to leverage these discoveries to engineer next-generation cellular and multi-specific immune-engager platforms to function effectively within the brain tumor microenvironment.

Kirk Hansen PhD

Professor
Biochemistry and Molecular Genetics
We develop and apply advanced proteomics and biophysical approaches to define how extracellular matrix composition, post-translational modifications, and remodeling regulate disease processes, tissue injury, and biomaterial function.

Jeffrey Jacot PhD

Associate Professor
Biomedical Engineering
The Jacot Lab focuses on pediatric regenerative medicine, with core expertise in cardiac tissue, biomaterial interactions, and amniotic fluid and induced pluripotent human stem cells.

Noah Johnson PhD

Assistant Professor
Neurology
My lab develops novel cell and rodent models of Alzheimer's and other neurodegenerative diseases and uses them to elucidate underlying disease mechanisms and to test new targeted therapeutics.

Igor Kogut PhD

Associate Professor
Dermatology
Dr. Igor Kogut's laboratory focuses on developing translational cell and gene therapy platforms, including iPSC-based and universal gene-correction approaches for RDEB in collaboration with Drs. Bilousova and Roop, alongside synthetic mRNA-driven cellular rejuvenation strategies, cancer-selective plasmid systems, and rejuvenation-enhanced CAR-T therapies.

Melissa Krebs PhD

Associate Professor
Biomedical Engineering (CU-Boulder)
We are focused on technology development for fundamental study and engineering of connective and cardiac tissues.

Ramya Kumar PhD

Assistant Professor
Chemical and Biological Engineering (Colorado School of Mines)
The Kumar lab applies advanced polymer synthesis and characterization to solve problems at interfaces between biomolecules, synthetic materials, and cells.

Chelsea Magin PhD

Associate Professor
Biomedical Engineering
The Magin Lab engineers 3D models of lung tissue to help the world breathe easier. Specifically, we engineer cell culture platforms that mimic the dynamic and complex architecture, composition and mechanical properties of lung tissue to study lung disease and to screen potential therapeutic treatments.

Kristyn Masters PhD

Professor
Biomedical Engineering
The Masters Lab uses tissue engineering to model disease risk factors, onset, and progression. We have a particular interest in cardiovascular diseases, gynecological cancers, and neurological disorders, and we apply the knowledge gained from our disease models to inform the design of therapies that can be translated to the clinic.

Corey Neu PhD

Professor
Biomedical Engineering (CU-Boulder)
We are focused on technology development for fundamental study and engineering of connective and cardiac tissues.

Dae Won Park PhD

Associate Professor
Biomedical Engineering

Karin Payne PhD

Associate Professor
Orthopedics
Our lab is dedicated to developing innovative ways to repair damaged growth plates and joint cartilage-key tissues that help children grow and keep all of us moving comfortably.

Robin Shandas PhD

Distinguished Professor
Biomedical Engineering
The Shandas lab translates ideas into clinical use. With over 65 patents, >150 publications, 8 startup companies, over 70 graduate students mentored, and having founded the Biomedical Engineering Department, Dr. Shandas specializes in efficiently moving ideas from fantasy to reality. By incorporating concepts of creative play, lateral thinking, and business-oriented project development, the lab innovates new medical technologies, from devices to diagnostics, many of which are now being used clinically.

Arianne Theiss PhD

Professor
Gastroenterology and Hepatology
We elucidate the role and mechanism whereby mitochondrial signaling pathways contribute to gastrointestinal diseases, specifically inflammatory bowel diseases (IBD), colitis-associated cancer, and colorectal tumorigenesis.
CMS Login